Retatrutide vs Semaglutide: Receptor Targets, Structure and Research Differences
Retatrutide and semaglutide are both peptide-based compounds studied in metabolic research, but they are not simply stronger and weaker versions of the same molecule. Their most important difference is receptor pharmacology: semaglutide is designed primarily as a GLP-1 receptor agonist, whereas retatrutide is a triple agonist that engages GLP-1, GIP and glucagon receptors. This guide…









